Trials / Conditions / Large Cell Neuroendocrine Carcinoma
Large Cell Neuroendocrine Carcinoma
5 registered clinical trials studyying Large Cell Neuroendocrine Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expr NCT07278479 | Molecular Partners AG | Phase 1 / Phase 2 |
| Completed | Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma NCT04452292 | Charles Kunos | N/A |
| Recruiting | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted NCT03866382 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advance NCT03728361 | Dwight Owen | Phase 2 |
| Terminated | Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors NCT02709889 | AbbVie | Phase 1 / Phase 2 |